UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)
x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2018
or
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from_____to _____
Commission file number: 001-38448
XSPAND PRODUCTS LAB, INC.
(Exact Name of Registrant as Specified in Its Charter)

 

Nevada	82-2199200
(State or Other Jurisdiction	(IRS Employer
of Incorporation or Organization)	Identification Number)
909 New Brunswick Ave
Phillipsburg, New Jersey	08865
(Address of Principal Executive Offices)	(Zip Code)
(610) 829-1039
(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes ¨ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)

x Yes ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer ¨	Smaller Reporting Company x
(Do not check if smaller reporting company)	Emerging Growth Company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

¨ Yes x No

 

As of August 13, 2018, there were 4,387,920 shares of the registrant’s common stock outstanding.

 

 

XSPAND PRODUCTS LAB, INC.

 

TABLE OF CONTENTS

 

		Page Number
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017	4
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 (unaudited)	5
	Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) for the six months ended June 30, 2018 (unaudited)	6
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)	7
	Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	23
SIGNATURES		24

 

OTHER PERTINENT INFORMATION

 

Unless the context otherwise indicates, when used in this report, the terms “Xspand Products Lab,” “we,” “us,” “our” and similar terms refer to Xspand Products Lab, Inc., a Nevada corporation formerly known as Idea Lab Products, Inc., and our subsidiaries S.R.M. Entertainment Limited (“SRM”), Ferguson Containers, Inc. (“Fergco”) and CBAV1, LLC (“CB”).

 

Unless otherwise indicated, all share and per share information contained herein gives effect to the 1:33333 reverse stock split of our common stock, which was effective February 14, 2018.

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events (including, without limitation, the terms, timing and closing of our proposed acquisition of the voting membership interests of Edison Nation Holdings, LLC) or our future financial performance. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “expects,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predict,” “should” or “will” or the negative of these terms or other comparable terminology. These statements are only predictions; uncertainties and other factors may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Our expectations are as of the date this Quarterly Report is filed, and we do not intend to update any of the forward-looking statements after the date this Quarterly Report is filed to confirm these statements to actual results, unless required by law.

 

You should not place undue reliance on forward looking statements. The cautionary statements set forth in this Quarterly Report identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

 

·

Our ability to effectively execute our business plan;

​ 

·

Our ability to manage our expansion, growth and operating expenses;

​ 

·

Our ability to protect our brands and reputation;

​ 

·

Our ability to repay our debts;

​ 

·

Our ability to rely on third-party suppliers outside of the United States;

​ 

·

Our ability to evaluate and measure our business, prospects and performance metrics;

​ 

·

Our ability to compete and succeed in a highly competitive and evolving industry; and

​ 

·

Our ability to respond and adapt to changes in technology and customer behavior.

 ​

This Quarterly Report also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other industry data. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. We have not independently verified the statistical and other industry data generated by independent parties and contained in this Quarterly Report and, accordingly, we cannot guarantee their accuracy or completeness, though we do generally believe the data to be reliable. In addition, projections, assumptions and estimates of our future performance and the future performance of the industries in which we operate are necessarily subject to a high degree of uncertainty and risk due to a variety of factors. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including, but not limited to, the possibility that we may fail to preserve our expertise in consumer product development; that existing and potential distribution partners may opt to work with, or favor the products of, competitors if our competitors offer more favorable products or pricing terms; that we may be unable to maintain or grow sources of revenue; that changes in the distribution network composition may lead to decreases in query volumes; that we may be unable to attain and maintain profitability; that we may be unable to attract and retain key personnel; or that we may not be able to effectively manage, or to increase, our relationships with customers; that we may have unexpected increases in costs and expenses. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

 

 

PART I - FINANCIAL INFORMATION

 

Xspand Products Lab, Inc. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

 

		June 30, 2018 (Unaudited)				December 31, 2017
Assets
Current assets:
Cash and cash equivalents		$	3,930,844			$	557,268
Accounts receivable, net			1,654,502				1,430,236
Inventory			227,630				240,061
Prepaid expenses and other current assets			1,159,731				41,461
Loan held for investment			500,000				-
Due from related party			1,250,959				834,897
Total current assets			8,723,666				3,103,923
Property and equipment, net			915,104				966,904
Total assets		$	9,638,770			$	4,070,827
Liabilities and stockholders' equity (deficit)
Current liabilities:
Accounts payable		$	1,283,748			$	1,135,039
Accrued expenses and other current liabilities			386,182				137,709
Current portion of notes payable - related parties			264,896				225,553
Total current liabilities			1,934,826				1,498,301
Notes payable - related parties, non-current			2,653,011				2,770,947
Deferred tax liability			34,209				34,209
Total liabilities		$	4,622,046			$	4,303,457
Commitments and contingencies (Note 9)
Stockholders' equity (deficit)
Common stock, $0.001 par value, 250,000,000 shares authorized; 4,368,930 and 3,000,000 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively		$	4,369			$	3,000
Additional paid-in capital			7,551,951				-
Accumulated deficit			(2,539,596	)			(235,630	)
Total stockholders’ equity (deficit)			5,016,724				(232,630	)
Total liabilities and stockholders’ equity (deficit)		$	9,638,770			$	4,070,827

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

Xspand Products Lab, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
Revenues, net		$	4,387,197			$	4,534,970			$	7,818,527			$	8,396,746
Cost of revenues			3,124,221				3,285,443				5,453,215				6,083,115
Gross profit			1,262,976				1,249,527				2,365,312				2,313,631
Operating expenses:
Selling, general and administrative			1,352,438				655,224				2,183,925				1,163,043
Selling, general and administrative - stock-based compensation expense			306,000				-				2,027,250				-
Total operating expenses			1,658,438				655,224				4,211,175				1,163,043
Operating (loss) income			(395,462	)			594,303				(1,845,863	)			1,150,588
Other (expense) income:
Rental income			25,703				25,703				51,407				51,407
Interest (expense) income			(277,602	)			1,252				(365,137	)			2,443
Total other (expense) income			(251,899	)			26,955				(313,730	)			53,850
(Loss) income before income taxes			(647,361	)			621,258				(2,159,593	)			1,204,438
Income tax expense			79,300				47,486				144,373				91,225
Net (loss) income		$	(726,661	)		$	573,772			$	(2,303,966	)		$	1,113,213
Net (loss) income per share
- basic and diluted		$	(0.18	)		$	0.19			$	(0.66	)		$	0.37
Weighted average number of common shares outstanding – basic and diluted			3,932,084				3,000,000				3,468,617				3,000,000

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

Xspand Products Lab, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

  

			Common Stock								Additional Paid-in				Accumulated				Total Stockholders’
			Shares				Amount				Capital				Deficit				Equity
Balance, December 31, 2017			3,000,000			$	3,000			$	-			$	(235,630	)		$	(232,630	)
Sale of common stock – investors in the IPO			1,294,230				1,294				6,469,856								6,471,150
Shares to be issued – investors in the IPO											91,450								91,450
Offering costs – IPO											(1,204,030	)							(1,204,030	)
Issuance of common stock – employees for services			61,200				61				305,939								306,000
Issuance of common stock – note holder			13,500				14				67,486								67,500
Shares to be issued – note holder											100,000								100,000
Stock-based compensation for assumption of consulting agreements											1,721,250								1,721,250
Net loss															(2,303,966	)			(2,303,966	)
Balance, June 30, 2018			4,368,930			$	4,369			$	7,551,951			$	(2,539,596	)		$	5,016,724

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

Xspand Products Lab, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

		For the Six Months Ended June 30,
		2018				2017
Cash Flow from Operating Activities
Net (loss) income		$	(2,303,966	)		$	1,113,213
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization			79,262				102,934
Amortization of financing costs			266,944				-
Stock-based compensation			2,027,250				-
Changes in assets and liabilities:
Accounts receivable			(224,266	)			(299,011	)
Inventory			12,431				(16,049	)
Prepaid expenses and other current assets			(1,118,270	)			29,220
Accounts payable			148,709				128,316
Accrued expenses and other current liabilities			248,473				178,870
Due from related party			(416,062	)			(396,418	)
Net cash (used in) provided by operating activities			(1,279,495	)			841,075
Cash Flows from Investing Activities
Purchases of property and equipment			(27,462	)			(44,264	)
Purchase of loan held for investment			(500,000	)			-
Net cash used in investing activities			(527,462	)			(44,264	)
Cash Flows from Financing Activities
Borrowings under notes payable			645,000				-
Repayments under notes payable – related parties			(78,593	)			-
Repayments under notes payable			(645,000	)			-
Net proceeds from sale of common stock			5,358,570				-
Fees paid for financing costs			(99,444	)			-
Dividends paid			-				(779,277	)
Net cash provided by (used in) financing activities			5,180,533				(779,277	)
Net increase in cash and cash equivalents			3,373,576				17,534
Cash and cash equivalents - beginning of period			557,268				2,534,753
Cash and cash equivalents - end of period		$	3,930,844			$	2,552,287
Supplemental Disclosures of Cash Flow Information
Cash paid during the period for:
Interest		$	62,623			$	-
Income taxes		$	-			$	-
Shares issued to note holders		$	67,500				-
Shares to be issued to note holders		$	100,000				-

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Business Organization and Nature of Operations

 

Xspand Products Lab, Inc. (“Xspand”) was incorporated on July 18, 2017 under the laws of the State of Nevada as Idea Lab X Products, Inc. On October 26, 2017, Idea Lab X Products, Inc. changed its name to Xspand Products Lab, Inc.

 

As of June 30, 2018, Xspand had three wholly-owned subsidiaries (collectively, the “Company”): S.R.M. Entertainment Limited (“SRM”), Ferguson Containers, Inc. (“Fergco”) and CBAV1, LLC (“CB”). SRM was incorporated in Hong Kong on January 14, 1981 and primarily designs, manufactures and sells a broad variety of innovative toy products directly to retailers or direct to consumers via ecommerce in North America, Asia and Europe. Fergco was incorporated on September 14, 1966 under the laws of the State of New Jersey. Fergco primarily designs, manufactures and sells packaging and packaging materials for industrial and pharmaceutical companies in North America.

 

On September 30, 2017, SRM and Fergco were acquired by Xspand in exchange for an aggregate of 3,000,000 shares of Xspand common stock and notes payable aggregating $2,996,500. This transaction between entities under common control resulted in a change in reporting entity and required retrospective combination of the entities for all periods presented, as if the combination had been in effect since the inception of common control. Accordingly, the condensed consolidated financial statements of Xspand reflect the accounting of the combined acquired subsidiaries at historical carrying values, except that equity reflects the equity of Xspand.

 

CB was formed on May 14, 2018 under laws of the State of Nevada. CB was formed for the purpose of purchasing a promissory note from a bank, at a discount from face value, of a company in financial difficulty. CB currently has no operations and only holds the note as a loan held for investment.

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2018 and the results of operations, changes in stockholders’ equity (deficit), and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the operating results for the full fiscal year for any future period.

 

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended December 31, 2017, and updated, as necessary, in this Quarterly Report on Form 10-Q.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Xspand and its wholly-owned subsidiaries, SRM, Fergco and CB. All intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements.

 

The Company’s significant estimates used in these financial statements include, but are not limited to, accounts receivable reserves, loan loss reserves, the valuation allowance related to the Company’s deferred tax assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of Significant Accounting Policies — (Continued)

 

Inventory

 

Inventory is recorded at the lower of cost or net realizable value on a first-in, first-out basis. The Company reduces the carrying value of inventories for those items that are potentially excess, obsolete, or slow moving based on changes in customer demand, technology developments, or other economic factors.

 

Loan Held for Investment

 

Loan held for investment is reported on the balance sheet at the acquired cost which approximates the fair value, which resulted in a discount. The acquired loan had evidence of deterioration of credit quality and for which it was probable, at the time of our acquisition, that the Company would be unable to collect all contractually required payments. For these loans, the excess of the undiscounted contractual cash flows over the undiscounted cash flows estimated by us at the time of acquisition was not accreted into income (nonaccretable discount). The amount representing the excess of cash flows estimated by us at acquisition over the purchase price was accreted into purchase discount earned over the life of the applicable loans (accretable discount). The nonaccretable discount was not accreted into income. If cash flows could not be reasonably estimated for any loan, and collection was not probable, the cost recovery method of accounting was used. Under the cost recovery method, any amounts received were applied against the recorded amount of such loans.

 

Subsequent to acquisition, if cash flow projections improved, and it was determined that the amount and timing of the cash flows related to the nonaccretable discount was reasonably estimable and collection was probable, the corresponding decrease in the nonaccretable discount was transferred to the accretable discount and was accreted into interest income over the remaining life of any such loan on the interest method. If cash flow projections deteriorated subsequent to acquisition, the decline was accounted for through the allowance for loan losses. Depending on the timing of an acquisition, the initial allocation of discount generally was made primarily to nonaccretable discount until the Company boarded all loans onto its servicing system; at that time, any cash flows expected to be collected over the purchase price were transferred to accretable discount. Generally, the allocation was finalized no later than ninety days from the date of purchase.

 

Revenue Recognition

 

Generally, the Company considers all revenues as arising from contracts with customers. Revenue is recognized based on the five step process outlined in the Accounting Standards Codification (“ASC”) 606:

 

Step 1 – Identify the Contract with the Customer – A contract exists when (a) the parties to the contract have approved the contract and are committed to perform their respective obligations, (b) the entity can identify each party’s rights regarding the goods or services to be transferred, (c) the entity can identify the payment terms for the goods or services to be transferred, (d) the contract has commercial substance and it is probably that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer.

 

Step 2 – Identify Performance Obligations in the Contract – Upon execution of a contract, the Company identifies as performance obligations each promise to transfer to the customer either (a) goods or services that are distinct, or (b) a series of distinct goods or services that are substantially the same and have the same pattern of transfer to the customer. To the extent a contract includes multiple promised goods or services, the Company must apply judgement to determine whether the goods or services are capable of being distinct within the context of the contract. If these criteria are not met, the goods or services are accounted for as a combined performance obligation.

 

Step 3 – Determine the Transaction Price – When (or as) a performance obligation is satisfied, the Company shall recognize as revenue the amount of the transaction price that is allocated to the performance obligation. The contract terms are used to determine the transaction price. Generally, all contracts include fixed consideration. If a contract did include variable consideration, the Company would determine the amount of variable consideration that should be included in the transaction price based on expected value method. Variable consideration would be included in the transaction price, if in the Company’s judgement, it is probable that a significant future reversal of cumulative revenue under the contract would not occur.

 

Step 4 – Allocate the Transaction Price – After the transaction price has been determined, the next step is to allocate the transaction price to each performance obligation in the contract. If the contract only has one performance obligation, the entire transaction price will be applied to that obligation. If the contract has multiple performance obligations, the transaction price is allocated to the performance obligations based on the relative standalone selling price (SSP) at contract inception.

 

Step 5 – Satisfaction of the Performance Obligations (and Recognize Revenue) – Revenue is recognized when (or as) goods or services are transferred to a customer. The Company satisfies each of its performance obligations by transferring control of the promised good or service underlying that performance obligation to the customer. Control is the ability to direct the use of, and obtain substantially all of the remaining benefits from an asset. It includes the ability to prevent other entities from directing the use of, and obtaining the benefits from an asset. Indicators that control has passed to the customer include: a present obligation to pay; physical possession of the asset; legal title; risks and rewards of ownership; and acceptance of the asset(s). Performance obligations can be satisfied at a point in time or over time.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of Significant Accounting Policies — (Continued)

 

Substantially all of the Company’s revenues continue to be recognized when control of the goods are transferred to the customer, which is upon shipment of the finished goods to the customer. All sales have fixed pricing and there are currently no variable components included in the Company’s revenue. Additionally, the Company will issue credits for defective merchandise, historically these credits for defective merchandise have not been material. Based on the Company’s analysis of the new revenue standards, revenue recognition from the sale of finished goods to customers, which represents substantially all of the Company’s revenues, was not impacted by the adoption of the new revenue standards.

 

Disaggregation of Revenue

 

The Company’s primary revenue streams include the sale of goods for innovative toy products (SRM) and packaging materials to industrial and pharmaceutical companies (Fergco).

 

For a presentation of the Company’s revenues disaggregated by segment, see Note 11, Segment Reporting.

 

Fair Value of Financial Instruments

 

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”) which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

 

Level 1 — quoted prices in active markets for identical assets or liabilities

 

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

 

Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions)

 

The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair values due to the short-term nature of these instruments. The carrying amount of the Company’s notes payable approximates fair value because the effective yields on these obligations, which include contractual interest rates, taken together with other features such as concurrent issuance of warrants, are comparable to rates of returns for instruments of similar credit risk. The loan held for investment was acquired at fair value, which resulted in a discount.

 

As of June 30, 2018, the book value and estimated fair value of the Company’s loan held for investment was as follows:

 

		June 30, 2018
		Book Value				Estimated Fair Value
Loan held for investment		$	500,000			$	500,000

  

Financial instruments for which fair value is disclosed but not required to be recognized in the balance sheet on a recurring basis consisted of the following:

 

		June 30, 2018
		Total				Level 1				Level 2				Level 3
Loan held for investment		$	500,000				-				-			$	500,000

 

The following changes in level 3 instruments for the three months ended June 30, 2018 are presented below:

 

						Level 3
Balance, April 1, 2018							-
Purchases							500,000
Balance, June 30, 2018							500,000

 

The following changes in level 3 instruments for the six months ended June 30, 2018 are presented below:

 

						Level 3
Balance, January 1, 2018							-
Purchases							500,000
Balance, June 30, 2018							500,000

 

Foreign Currency Translation

 

The Company uses the United States dollar as its functional and reporting currency since the majority of the Company’s revenues, expenses, assets and liabilities are in the United States. Assets and liabilities in foreign currencies (HK dollars) are translated using the exchange rate at the balance sheet date, while revenue and expense accounts are translated at the average exchange rates prevailing during the year. Equity accounts are translated at historical exchange rates. Gains and losses from foreign currency transactions and translation for the three and six months ended June 30, 2018 and 2017 and the cumulative translation gains and losses as of June 30, 2018 and December 31, 2017 were not material.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of Significant Accounting Policies — (Continued)

 

Income Taxes

 

The Company accounts for income taxes under the provisions of the Financial Accounting Standards Board (“FASB”) ASC Topic 740 “Income Taxes” (“ASC Topic 740”).

 

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

 

The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

 

Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s condensed consolidated financial statements as of June 30, 2018 and December 31, 2017. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.

 

The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the statements of operations.

 

On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA”) was signed into law. This legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a repatriation tax on deemed repatriated earnings of foreign subsidiaries. The TCJA permanently reduced the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018.

 

The staff of the SEC issued Staff Accounting Bulletin No. 118 to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the TCJA. Although the Company is unable to make a reasonable estimate on the full effect on our income taxes as of the date of this report, the Company remeasured its deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. The remeasurement of the Company's deferred tax assets and liabilities was offset by a change in the valuation allowance.

 

The Company is still in the process of analyzing the impact to the Company of the TCJA. Where the Company has been able to make reasonable estimates of the effects related to which its analysis is not yet complete, the Company has recorded provisional amounts. The ultimate impact to the Company’s condensed consolidated financial statements of the TCJA may differ from the provisional amounts due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the TCJA. The accounting is expected to be complete when the Company’s 2017 U.S. corporate income tax return is filed in 2018.

 

Net Earnings or Loss per Share

 

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of vested common shares outstanding during the period, adjusted to give effect to the 1-for-3.333333 reverse stock split, which was effected on February 14, 2018. Diluted net income per common share is computed by dividing net income by the weighted average number vested of common shares, plus the net impact of common shares (computed using the treasury stock method), if dilutive, resulting from the exercise of dilutive securities. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of June 30, 2017, there were no common stock equivalents outstanding. As of June 30, 2018, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.

 

		June 30,
		2018
Selling Agent Warrants to be issued for the purchase of common stock			65,626
Shares to be issued, see Note 10			38,290
			103,916

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of Significant Accounting Policies — (Continued)

 

Concentrations

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivables and revenues.

 

The Company has cash on deposits in several financial institutions which, at times, may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced losses in such accounts and periodically evaluates the creditworthiness of its financial institutions. The Company reduces its credit risk by placing its cash and cash equivalents with major financial institutions. The Company had approximately $3,220,000 uninsured at June 30, 2018. The Company held cash of approximately $360,000 in foreign bank accounts as of June 30, 2018.

 

For the three and six months ended June 30, 2018 and 2017, the following customers represented more than 10% of total net revenues:

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
Customer A			23	%			30	%			25	%			28	%
Customer B				*			12	%				*				*
Customer C				*				*			11	%				*

* Customer did not represent greater than 10% of total net revenue.

 

As of June 30, 2018, the following customers represented more than 10% of total accounts receivable:

 

		June 30,
		2018
Customer A			13	%
Customer B			14	%

 

For the three and six months ended June 30, 2018 and 2017, the following geographical regions represented more than 10% of total net revenues:

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
North America			82	%			81	%			80	%			82	%
Asia-Pacific			15	%			14	%			17	%			12	%

 

Deferred Financing Costs

 

Deferred financing costs include debt discounts and debt issuance costs related to a recognized debt liability and are presented in the balance sheet as a direct deduction from the carrying value of the debt liability. Amortization of deferred financing costs are included as a component of interest expense. Deferred financing costs are amortized using the straight-line method over the term of the recognized debt liability which approximates the effective interest method.

 

Offering Costs

 

Costs directly attributable to the Company’s Regulation A initial public offering (“IPO”) of equity securities were deferred prior to the completion of the IPO and charged against the gross proceeds of the offering as a reduction of additional paid-in capital at the time of the IPO. These costs included legal fees to draft the Company’s offering statement and provide counsel related to the IPO, fees incurred by the independent registered public accounting firm directly related to the IPO, fees incurred by financial reporting advisors directly related to the IPO, SEC filing, printing and distribution expenses, roadshow expenses and exchange listing fees.

 

Subsequent Events

 

The Company has evaluated subsequent events through the date which the financial statements were issued. Based upon the evaluation, except for items described in Note 12, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

 

Segment Reporting

 

The Company uses “the management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s chief operating decision maker is the Chairman and Chief Executive Officer (“CEO”) of the Company, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. The Company classified the reportable operating segments into (i) design, manufacture and sale of a broad variety of innovative toy products sold directly to retailers or direct to consumers via ecommerce in North America, Asia and Europe by SRM and (ii) the design, manufacture and sale of packaging and packaging materials to industrial and pharmaceutical companies in North America by Fergco. CB does not have any reportable operations. Therefore, as of June 30, 2018, CB is not classified in either of the Company’s operating segments.

 

Note 3 — Inventory

 

As of June 30, 2018 and December 31, 2017, inventory consisted of the following:

 

		June 30,				December 31,
		2018				2017
Raw materials		$	31,512			$	30,410
Finished goods			196,118				209,651
Total inventory		$	227,630			$	240,061

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 4 — Prepaid expenses and other current assets

 

As of June 30, 2018 and December 31, 2017, prepaid expenses and other current assets consisted of the following:

 

		June 30,				December 31,
		2018				2017
Deposits for inventory		$	1,033,329			$	-
Deposits			-				22,814
Prepaid insurance			31,035				-
Other			95,367				18,647
Total prepaid expenses and other current assets		$	1,159,731			$	41,461

 

Note 5 — Loan held for investment

 

On June 4, 2018, the Company purchased a promissory note for $500,000 from a bank at a discount from face value of a company in financial difficulty. As of June 30, 2018, the loan held-for-investment consisted of the following:

 

						June 30,
						2018
Cloud b, Inc., Promissory note, past due, Wall Street Journal prime rate plus 3% interest						$	2,270,000
Non-accretable purchase discount							(1,770,000	)
Total loan held-for-investment						$	500,000

 

The interest rate of the promissory note as of June 30, 2018 was 8%.

 

Note 6 — Income Taxes

 

United States and foreign components of (loss) income before income taxes were as follows:

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
United States		$	(1,308,118	)		$	(63,474	)		$	(3,367,603	)		$	(11,891	)
Foreign			660,757				684,732				1,208,010				1,216,329
(Loss) income before income taxes		$	(647,361	)		$	621,258			$	(2,159,593	)		$	1,204,438

 

Fergco was a Subchapter S pass-through entity for income tax purposes prior to its acquisition by Xspand on September 30, 2017. Accordingly, Fergco was not subject to income taxes prior to the acquisition and therefore the tax provision related to the United States income is only for the period from January 1, 2018 to June 30, 2018.

 

The Company’s foreign entity is SRM, which is an entity subject to the Hong Kong, China tax regime. The Hong Kong tax returns remain subject to examination by local taxing authorities beginning with the tax year ended December 31, 2011.

 

The tax effects of temporary differences that give rise to deferred tax assets or liabilities are presented below:

 

		June 30,				December 31,
		2018				2017
Deferred tax assets:
Net operating loss carryforwards		$	796,320			$	50,524
Less: valuation allowance			(796,320	)			(50,524	)
Net deferred tax assets			-				-
Deferred tax liabilities:
Property and equipment			34,209				34,209
Deferred tax liabilities			34,209				34,209
Net deferred tax liabilities		$	34,209			$	34,209

 

The income tax provision consists of the following:

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
Current:
Federal		$	20,053			$	-			$	38,794			$	-
Foreign			49,557				47,486				90,601				91,225
State and local			9,690				-				14,978				-
Income tax provision		$	79,300			$	47,486			$	144,373			$	91,225

    

A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:

 

		For the Six Months Ended June 30,
		2018				2017
Tax at federal rate			21.0	%			34.0	%
U.S. income attributable to pass-through entity			0.0	%			-3.0	%
U.S. income subject to valuation allowance			-34.7	%			0.0	%
State and local income taxes			-0.5	%			0.0	%
Foreign income not subject to U.S. federal tax			11.7	%			-31.0	%
Foreign tax			-4.2	%			7.5	%
Effective income tax rate			-6.7	%			7.5	%

 

 

Note 7 — Notes Payable

 

The Company borrowed funds under two separate notes, aggregating $645,000, in February 2018 and March 2018. As of June 30, 2018, both holders of the notes were paid in full. In addition, the Company was required to issue 20,000 and 13,500 shares under the notes payable, respectively. The fair value of the shares to be issued was $167,500 which was recorded as a debt discount and fully amortized through interest expense. In May 2018, the Company issued 13,500 shares to the one note holder and 20,000 shares were still required to be issued as of June 30, 2018.

 

Note 8 — Related Party Transactions

 

As of June 30, 2018 and December 31, 2017, due from related party consists of amounts due from SRM Entertainment Group LLC (“SRM LLC”), which was the parent of SRM prior to its acquisition by Xspand, related to operating expenses that were paid for on behalf of one related party to the other related party. As of June 30, 2018 and December 31, 2017, the net amount due from related parties was $1,250,959 and $834,897, respectively. Such amounts are due currently.

 

In connection with the acquisition of SRM and Fergco, Xspand issued two notes payable aggregating $2,996,500. One note was issued to NL Penn Capital, L.P, in relation to the acquisition of SRM in the amount of $2,120,000 and the other note was issued to the stockholders of Fergco in the amount of $876,500. The notes bear interest at a rate of six percent (6%) per annum and have an effective interest rate of six percent (6%) per annum. Xspand is required to make monthly payments comprised of principal and interest beginning in January 2018 that are amortized over ten (10) years, with a balloon payment of all outstanding principal and interest due at the respective maturity dates ($677,698 due on December 1, 2020 and $1,249,043 due on December 1, 2022). Related party interest expense was $102,942 and $0 for the six months ended June 30, 2018 and 2017, respectively. The scheduled maturities of the notes payable for the next five years as of June 30, 2018, are as follows:

 

For the Years Ended December 31,		Amount
2018		$	146,957
2019			239,461
2020			254,230
2021			857,069
2022			1,420,190
		$	2,917,907

 

 

Note 9 — Commitments and Contingencies

 

Operating Lease

 

On August 8, 2016, SRM entered into a lease for office space in Kowloon, Hong Kong that expired on July 22, 2018. Monthly lease payments are approximately $6,000 for a total of approximately $152,000 for the total term of the lease. On August 8, 2018 the Company extended the lease in Kowloon, Hong Kong. See Note 12, Subsequent Events.

 

Total rent expense for the three months ended June 30, 2018 and 2017 was $82,510 and $83,218, respectively and total rent expense for the six months ended June 30, 2018 and 2017 was $146,536 and $126,328, respectively. Rent expense is included in general and administrative expense on the condensed consolidated statements of operations.

 

Rental Income

 

Fergco leases a portion of the building located in Washington, New Jersey that it owns under a month to month lease. Total rental income related to the leased space for both the three months ended June 30, 2018 and 2017 was $25,704, respectively, and $51,407 for both the six months ended June 30, 2018 and 2017, respectively and is included in other income on the condensed consolidated statements of operations.

 

Legal Contingencies

 

As of June 30, 2018, we were not a party to any material legal proceedings. However, the Company may be involved in claims and litigation in the ordinary course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 10 — Stockholders’ Equity

 

Reverse Stock Split

 

On February 14, 2018, Xspand effected a one-for-3.333333 reverse stock split of its issued and outstanding shares of common stock. All share information has been retroactively restated to reflect the aforementioned reverse stock split.

 

Common Stock

 

The Company was authorized to issue 250,000,000 shares of common stock, $0.001 par value, as of June 30, 2018 and December 31, 2017.

 

The Company issued 1,294,230 shares of common stock and will issue an additional 18,290 shares of common stock related to the IPO, at a public offering price of $5.00 per share in August 2018. The Company received gross proceeds of $6,562,600 and net proceeds of $5,358,570 after deducting underwriter commissions and expenses of $714,802, legal fees of $157,358, escrow closing fees of $4,000 and other direct offering expenses aggregating $1,204,030.

 

Stock-Based Compensation

 

On February 28, 2018, the Company agreed to assume certain consulting agreements entered into by SRM LLC, which was the parent of SRM prior to its acquisition by Xspand. Under these consulting agreements SRM LLC offered these consultants options to own stock if SRM LLC were ever sold for past considerations. As an accommodation to Xspand, the principal stockholder of SRM satisfied these agreements on behalf of the Company, by transferring 344,250 of his shares to the consultants. In accordance with SEC Staff Accounting Bulletin (SAB) 79 amended by SAB 5T, “Accounting for Expenses or Liabilities Paid by Principal Stockholder,” the Company recorded a noncash charge of $1,721,250 for the fair value of these shares.

 

The Company issued 61,200 shares of common stock to employees in connection with the IPO. The Company recorded a charge of $306,000 for the fair value of the 61,200 shares of common stock issued to employees for services.

 

Selling Agent Agreement

 

In connection with the IPO, the Company agreed to issue to the selling agent in the IPO, warrants to purchase a number of shares of the common stock equal to 5.0% of the total shares of common stock sold in any closing of the IPO, excluding shares purchased by investors sourced via alternative funding platforms (the “Selling Agent Warrants”). The Selling Agent Warrants are exercisable commencing on the qualification date of the IPO and have a term of 5 years. The Selling Agent Warrants are not redeemable by the Company. The exercise price for the Selling Agent Warrants will be 20% greater than the offering price, or $6.00. The Company will grant 65,626 of Selling Agent Warrants earned in connection with the IPO.

  

Note 11 — Segment Reporting

 

The Company’s principal operating segments coincide with the types of products to be sold. The products from which revenues are derived are consistent with the reporting structure of the Company’s internal organization. The Company’s two reportable segments for the three and six months ended June 30, 2018 and 2017 were the SRM segment and the Fergco segment. Xspand incurs operating expenses related to the corporate level and these costs are not allocated to the Company’s operating segments. CB does not have any reportable operations. The Company’s chief operating decision-maker has been identified as the Chairman and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon the Company’s management organization structure as of June 30, 2018 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed. There are no inter-segment revenue transactions and, therefore, revenues are only to external customers.

 

Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker. The Company derives the segment results from its internal management reporting system. The accounting policies the Company uses to derive reportable segment results are the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including net revenues, gross profit and operating loss. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. The Company manages certain operating expenses separately at the corporate level and does not allocate such expenses to the segments. Segment income from operations excludes interest income/expense and other income or expenses and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, and unallocated costs in measuring the performance of the reportable segments.

 

 

Xspand Products Lab, Inc. and Subsidiaries

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 11 — Segment Reporting — (Continued)

 

Segment information available with respect to these reportable business segments for the three and six months ended June 30, 2018 and 2017 was as follows:

 

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
Revenues:
Fergco		$	1,718,409			$	1,378,061			$	3,025,328			$	2,676,832
SRM			2,668,788				3,156,909				4,793,199				5,719,914
Total segment and consolidated revenues		$	4,387,197			$	4,534,970			$	7,818,527			$	8,396,746
Gross profit:
Fergco		$	500,285			$	352,295			$	860,722			$	705,441
SRM			762,691				897,232				1,504,590				1,608,190
Total segment and consolidated gross profit		$	1,262,976			$	1,249,527			$	2,365,312			$	2,313,631
Income (loss) from operations:
Fergco		$	83,664			$	(90,426	)		$	141,258			$	(65,738	)
SRM			660,637				684,729				1,207,890				1,216,326
Corporate			(1,139,763	)			-				(3,195,011	)			-
Total segment and consolidated (loss) income from operations		$	(395,462	)		$	594,303			$	(1,845,863	)		$	1,150,588
Depreciation and amortization:
Fergco		$	27,767			$	34,086			$	55,534			$	68,172
SRM			11,864				17,381				23,728				34,762
Total segment depreciation and amortization		$	39,631			$	51,467			$	79,262			$	102,934

   

		June 30,				December 31,
		2018				2017
Segment total assets:
Fergco		$	2,259,670			$	1,853,273
SRM			3,359,352				2,217,296
Corporate			4,019,748				258
Total segment and consolidated assets		$	9,638,770			$	4,070,827

 

Note 12 — Subsequent Events

 

Edison Nation Transaction

 

On June 29, 2018, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Edison Nation Holdings, LLC (“EN”) and all of the members of Edison Nation, LLC, pursuant to which the Company intends to acquire all of the voting membership interests of EN. As reported in the Company’s offering statement on Form 1-A dated April 25, 2018, the Company had previously begun negotiations for the acquisition pursuant to that certain Strategic Partnership Agreement dated February 26, 2018 and entered into between the Company and Edison Nation, LLC (a wholly-owned subsidiary of EN).

 

Pursuant to the Purchase Agreement, the Company agreed to pay aggregate consideration consisting of: (i) $700,000 in cash to EN ($550,000 of which will be used to purchase the membership interests of Access Innovation, LLC, which membership interests will then be subsequently distributed to the existing members of EN), (ii) $250,000 in cash to be used to pay off indebtedness of EN owed to holders of certain senior convertible debt and the assumption of the remaining balance of the senior convertible debt through the issuance to the holders of 4%, 5-year senior convertible notes (the “New Convertible Notes”), in the aggregate principal amount of the sum of $1,406,352 plus accrued but unpaid interest arising on the senior convertible debt through the closing date, which as of the date of the Purchase Agreement would be convertible into approximately 281,270 shares of the Company’s common stock, at the option of the holder of such New Convertible Notes (subject to certain adjustments as provided in the Purchase Agreement and the terms of the New Convertible Notes), (iii) the reservation of 990,000 shares of the Company’s common stock that may be issued in exchange for the redemption of certain non-voting membership interests of EN that will be created specifically in connection with the transaction contemplated by the Purchase Agreement (which exchange obligations may be instead satisfied in cash instead of shares of common stock, in the Company’s sole discretion), and (iv) the issuance of approximately 550,346 shares of the Company’s common stock in satisfaction of the indebtedness represented by promissory notes payable by EN to Venture Six, LLC and Wesley Jones with a total principal balance of $4,127,601.94 as of the date of the Purchase Agreement. In addition, the Company agreed to use its best efforts to cause Louis Foreman, a Member, manager, and principal of EN, to be nominated for election to the Company’s board of directors at the Company’s next annual meeting.

 

The terms of the Purchase Agreement are complex and only briefly summarized above. For further information, please refer to the descriptions of the Purchase Agreement and related agreements contained in the Company’s Current Report on Form 8-K filed with the SEC on July 6, 2018. The discussion herein is qualified in its entirety by reference to such filed documents.

 

The Company’s management expects the transaction contemplated by the Purchase Agreement to close during the third quarter of 2018.

 

Service Agreement

 

On August 1, 2018, the Company entered into a one-year letter agreement with Enventys Partners, LLC, a North Carolina limited liability company (“Enventys”), whereby Enventys agreed to provide services to the Company as an independent contractor in the areas of product development and crowdfunding campaign marketing. During the term of the Enventys Agreement, the Company shall pay Enventys a fixed fee of $15,000 per month for product development assistance, including design research, mechanical engineering and quality control planning. In addition, the Company agreed to pay a commitment fee of $250,000 for Enventys’ assistance in marketing ten rewards-based crowdfunding campaigns for the Company’s products. Depending on the success of each campaign, the Company may also pay Enventys a commission of up to ten percent of the total funds raised in the applicable campaign. One of the members of EN, Louis Foreman, is also the Chief Executive Officer and largest equity holder of Enventys.

 

Operating Lease

 

On August 8, 2018, SRM extended its lease for office space in Kowloon, Hong Kong that expires on August 7, 2020. Monthly lease payments are approximately $6,400 for a total of approximately $154,000 for the total term of the lease.

 

Common Stock

 

On July 3, 2018, the Company issued the 18,290 shares of common stock to investors in the IPO.

 

On July 11, 2018, the Company issued 700 shares of common stock to two employees for services performed.

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

This Quarterly Report on Form 10-Q, including the following section entitled Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements expressing management's current expectations, goals, objectives and similar matters. The following discussion pertains to our historical results, on a consolidated basis. However, because we conduct all of our material business operations through our wholly-owned subsidiaries, SRM, Fergco and CB, the discussion and analysis relates to activities primarily conducted at the subsidiary level. Historical results and trends that might appear in this Quarterly Report should not be interpreted as being indicative of future operations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and the notes thereto appearing in Part I, Item 1 of this Quarterly Report. The Company undertakes no obligation to revise the forward-looking statements in this report after the date of the filing. Unless otherwise specifically indicated, all dollar amounts in the tables in this section are in thousands of dollars, except per share data or when otherwise specifically noted.

 

Overview

 

Xspand Products Lab, Inc. (“Xspand”) was incorporated on July 18, 2017 under the laws of the State of Nevada as Idea Lab X Products, Inc. On October 26, 2017, Idea Lab X Products, Inc. changed its name to Xspand Products Lab, Inc. On February 14, 2018, Xspand effected a one-for-3.333333 reverse stock split of its issued and outstanding shares of common stock. All share information has been retroactively restated to reflect the aforementioned reverse stock split.

 

As of June 30, 2018, Xspand had three wholly-owned subsidiaries (collectively, the “Company”): S.R.M. Entertainment Limited (“SRM”), Ferguson Containers, Inc. (“Fergco”) and CBAV1, LLC (“CB”). On September 30, 2017, SRM and Fergco were acquired by Xspand in exchange for an aggregate of 3,000,000 shares of Xspand common stock and notes payable aggregating $2,996,500. This transaction between entities under common control resulted in a change in reporting entity and required retrospective combination of the entities for all periods presented, as if the combination had been in effect since the inception of common control. Accordingly, the consolidated financial statements of Xspand reflect the accounting of the combined acquired subsidiaries at historical carrying values, except that equity reflects the equity of Xspand.

 

SRM was incorporated in Hong Kong on January 14, 1981 and Fergco was incorporated on September 14, 1966 under the laws of the State of New Jersey. Our two reportable segments correspond to SRM and Fergco’s business lines: (i) the design, manufacture and sale of a broad variety of innovative toy products sold directly to retailers or direct to consumers via e-commerce in North America, Asia and Europe by our SRM segment, and (ii) the design, manufacture and sale of packaging and packaging materials to industrial and pharmaceutical companies in North America by our Fergco segment.

 

CB was formed on May 14, 2018 under laws of the State of Nevada, solely for the purpose of purchasing the $500,000 note that was originally issued by Cloud b, Inc., an entity with which the Company had previously entered into a manufacturing agreement, to a bank. See Note 5, Loan held for investment, of the Notes to Condensed Consolidated Financial Statements, in Part I of this Quarterly Report on Form 10-Q for more information. As such, CB does not currently have operations, only holds the foregoing note, and is correspondingly not included in either of the Company’s reportable operating segments.

 

Factors Which May Influence Future Results of Operations

 

The following is a description of factors which may influence our future results of operations, and which we believe are important to an understanding of our business and results of operations.

 

Financial Overview

 

Revenues

 

We generate revenues through our two reportable segments. Through our SRM segment, we sell a broad variety of innovative toy products directly to retailers or direct to consumers via e-commerce in North America, Asia and Europe. Through Fergco, we sell packaging and packaging materials principally to industrial and pharmaceutical companies in North America.

 

 

Cost of Revenues

 

Our cost of revenues includes inventory costs, materials and supplies costs, internal labor costs and related benefits, subcontractor costs, depreciation, overhead and shipping and handling costs.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses consist of selling, marketing, advertising, payroll, administrative, finance and professional expenses.

 

Rental Income

 

We earn rental income from a month-to-month lease on a portion of the building located in Washington, New Jersey that we own.

 

Critical Accounting Policies

 

The preparation of financial statements and related disclosures in conformity with U.S. generally accepted accounting principles (“US GAAP”) and our discussion and analysis of our financial condition and operating results requires management to make judgments, assumptions and estimates that affect the amounts reported in our consolidated financial statements and accompanying notes. Note 2, “Summary of Significant Accounting Policies,” of the Notes to our condensed consolidated financial statements appearing elsewhere in this report describes the significant accounting policies and methods used in the preparation of our consolidated financial statements. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates, and such differences may be material.

 

There have been no significant changes in our critical accounting policies during the three and six months ended June 30, 2018 as compared to the critical accounting policies described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017. We believe these critical accounting policies involve the more significant judgments and estimates used in the preparation of our consolidated financial statements and are the most critical to aid you in fully understanding and evaluating our reported financial results. Management considers these policies critical because they are both important to the portrayal of our financial condition and operating results, and they require management to make judgments and estimates about inherently uncertain matters.

 

Off-Balance Sheet Arrangements

 

We did not have and were not a party to, during the periods presented, any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Results of Operations

 

Three months ended June 30, 2018 versus three months ended June 30, 2017

 

Revenue

 

For the three months ended June 30, 2018 and 2017, total segment and consolidated revenues consisted of the following:

 

		For the Three Months Ended June 30,
		2018				2017
Revenues:
Fergco		$	1,718,409			$	1,378,061
SRM			2,668,788				3,156,909
Total segment and consolidated revenues		$	4,387,197			$	4,534,970

 

 

For the three months ended June 30, 2018, revenues from our Fergco segment increased by $340,348 or 25%, as compared to the three months ended June 30, 2017. The increase was primarily attributable to increased product demand from our existing customers that have experienced increased demand from their own customers.

 

For the three months ended June 30, 2018, revenues from our SRM segment decreased by $488,121 or 15%, as compared to the three months ended June 30, 2017. The decrease was primarily attributable to the Walt Disney Company’s theme park safety officers terminating sales of toy weapons in response to school shootings in the United States.

 

Cost of Revenues

 

For the three months ended June 30, 2018 and 2017, total segment and consolidated cost of revenues consisted of the following:

 

		For the Three Months Ended June 30,
		2018				2017
Cost of revenues:
Fergco		$	1,218,124			$	1,025,766
SRM			1,906,097				2,259,677
Total segment and consolidated cost of revenues		$	3,124,221			$	3,285,443

 

For the three months ended June 30, 2018, cost of revenues decreased by $161,222 or 5%, as compared to the three months ended June 30, 2017. The decrease was primarily attributable to the decrease in total segment and consolidated revenues.

 

Gross Profit

 

Gross profit and gross margin by segment and totals are as follows:

 

		For the Three Months Ended June 30,
		2018				2017
Gross profit:
Fergco		$	500,285			$	352,295
SRM			762,691				897,232
Total segment and consolidated gross profit		$	1,262,976			$	1,249,527

 

For the three months ended June 30, 2018, gross profit for our Fergco segment increased by $147,990, or 42%, as compared to the three months ended June 30, 2017. The increase was primarily a result of the increase in revenues. For the three months ended June 30, 2018, gross margin increased to 29%, as compared to 26% for the three months ended June 30, 2017. The increase is primarily a result of lower per unit fixed costs due to the increase in revenues.

 

For the three months ended June 30, 2018, gross profit for our SRM segment decreased by $134,541, or 15%, as compared to the three months ended June 30, 2017. The decrease was primarily a result of the decrease in revenues. For the three months ended June 30, 2018, gross margin increased to 29%, as compared to 28% for the three months ended June 30, 2017.

 

Operating Expenses

 

Selling, general and administrative expenses were $1,658,438 and $655,224 for the three months ended June 30, 2018 and 2017, respectively, representing an increase of $1,003,214, or 153%. The increase was primarily attributable to certain indirect costs incurred related to the IPO and increased salaries related to the hiring of Xspand employees and executives during the three months ended June 30, 2018. Stock-based compensation expense was $306,000 related to the issuance of 61,200 shares of common stock to employees. The Company expects operating expenses to continue to increase as a public company and the Company’s expected future growth.

 

Rental income

 

Rental income was $25,703 for both the three months ended June 30, 2018 and 2017.

 

Six months ended June 30, 2018 versus six months ended June 30, 2017

 

Revenue

 

For the six months ended June 30, 2018 and 2017, total segment and consolidated revenues consisted of the following:

 

		For the Six Months Ended June 30,
		2018				2017
Revenues:
Fergco		$	3,025,328			$	2,676,832
SRM			4,793,199				5,719,914
Total segment and consolidated revenues		$	7,818,527			$	8,396,746

 

 

For the six months ended June 30, 2018, revenues from our Fergco segment increased by $348,496 or 13%, as compared to the six months ended June 30, 2017. The increase was primarily attributable to increased product demand from our existing customers that have experienced increased demand from their own customers.

 

For the six months ended June 30, 2018, revenues from our SRM segment decreased by $926,715 or 16%, as compared to the six months ended June 30, 2017. The decrease was primarily attributable to the Walt Disney Company’s theme park safety officers terminating sales of toy weapons in response to school shootings in the United States.

 

Cost of Revenues

 

For the six months ended June 30, 2018, total segment and consolidated cost of revenues consisted of the following:

 

		For the Six Months Ended June 30,
		2018				2017
Cost of revenues:
Fergco		$	2,164,606			$	1,971,391
SRM			3,288,609				4,111,724
Total segment and consolidated cost of revenues		$	5,453,215			$	6,083,115

 

For the six months ended June 30, 2018, cost of revenues decreased by $629,900 or 10%, as compared to the six months ended June 30, 2017. The decrease was primarily attributable to the decrease in total segment and consolidated revenues.

 

Gross Profit

 

Gross profit and gross margin by segment and totals are as follows:

 

		For the Six Months Ended June 30,
		2018				2017
Gross profit:
Fergco		$	860,722			$	705,441
SRM			1,504,590				1,608,190
Total segment and consolidated gross profit		$	2,365,312			$	2,313,631

 

For the six months ended June 30, 2018, gross profit for our Fergco segment increased by $155,281, or 22%, as compared to the six months ended June 30, 2017. The increase was primarily a result of the increase in revenues. For the six months ended June 30, 2018, gross margin increased to 28%, as compared to 26% for the six months ended June 30, 2017. The increase is primarily a result of lower per unit fixed costs due to the increase in revenues.

 

For the six months ended June 30, 2018, gross profit for our SRM segment decreased by $103,600, or 6%, as compared to the six months ended June 30, 2017. These decreases were primarily a result of the decrease in revenues. For the six months ended June 30, 2018, gross margin increased to 31%, as compared to 28% for the six months ended June 30, 2017. The increase is primarily a result of favorable product mix.

 

Operating Expenses

 

Selling, general and administrative expenses were $4,211,175 and $1,163,043 for the six months ended June 30, 2018 and 2017, respectively, representing an increase of $3,048,132, or 262%. The increase was primarily attributable to stock-based compensation expense of $2,027,250 related to the assumption of certain consulting agreements which were satisfied by the principal stockholder of SRM transferring 344,250 shares to the consultants and the issuance of 61,200 shares of common stock to employees, indirect costs incurred related to the IPO and increased salaries related to the hiring of Xspand employees and executives during the six months ended June 30, 2018. The Company expects operating expenses to continue to increase as a public company and the Company’s expected future growth.

 

Rental income

 

Rental income was $51,407 for both the six months ended June 30, 2018 and 2017.

  

Non-GAAP Measures

 

EBITDA and Adjusted EBITDA - The Company defines EBITDA as net income (loss) before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, further adjusted to eliminate the impact of certain non-recurring items and other items that we do not consider in our evaluation of our ongoing operating performance from period to period. These items will include stock-based compensation, restructuring and severance costs, transaction costs, acquisition costs, certain other non-recurring charges and gains that the Company does not believe reflects the underlying business performance.

 

For the three and six months ended June 30, 2018 and 2017, EBITDA and Adjusted EBITDA consisted of the following: 

  

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2018				2017				2018				2017
Net (loss) income		$	(726,661	)		$	573,772			$	(2,303,966	)		$	1,113,213
Interest expense, net			277,602				(1,252	)			365,137				(2,443	)
Income tax expense			79,300				47,486				144,373				91,225
Depreciation and amortization			39,631				51,467				79,262				102,934
EBITDA			(330,128	)			671,473				(1,715,194	)			1,304,929
Stock-based compensation			306,000				-				2,027,250				-
Restructuring and severance costs			18,000				-				18,000				-
Transaction and acquisition costs			150,702				-				150,702				-
Other non-recurring costs			63,386				-				63,386				-
Adjusted EBITDA		$	207,960			$	671,473			$	544,144			$	1,304,929

 

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as restructuring costs, litigation or dispute settlement charges or gains, and transaction-related costs), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period.  The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

 

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

 

 

Liquidity and Capital Resources

 

At June 30, 2018, we had total current assets of $8,723,666 and current liabilities of $1,934,826 resulting in working capital of $6,788,840. At June 30, 2018, we had total assets of $9,638,770 and total liabilities of $4,622,046 resulting in stockholders’ equity of $5,016,724.

 

At June 30, 2018, we had $2,917,907 of outstanding notes payable due to our related parties of which $264,896 was the current portion. These notes arose as part of the consideration paid in our acquisition of SRM and Fergco.

 

On May 2, 2018, we completed our IPO raising $6,562,600 in gross proceeds. The Company received approximately $5,358,570 in net proceeds after deducting discounts and commissions and other offering expenses. At June 30, 2018, we had a cash and cash equivalents balance of $3,930,844. The Company believes that the funds available to it are adequate to meet its working capital needs, debt service and capital requirements for the next 12 months from the date of this filing.

 

Thereafter, we may need to raise further capital, through the sale of additional equity or debt securities, to support our future operations. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings.

 

During the six months ended June 30, 2018 and 2017 our sources and uses of cash were as follows:

 

Cash Flows from Operating Activities

 

Net cash used in operating activities for the six months ended June 30, 2018 was $1,279,495 which included a net loss of $2,303,966 which was offset by noncash stock-based compensation of $2,027,250 and $1,348,985 of cash used by changes in operating assets and liabilities mostly related to our deposits with factories. Net cash provided by operating activities for the six months ended June 30, 2017 was $841,075, which included cash provided by net income of $1,113,213, which was partially offset by $375,072 of cash used in changes in operating assets and liabilities.

 

Cash Flows from Investing Activities

 

Net cash used in investing activities was $527,462 and $44,264 for the six months ended June 30, 2018 and 2017, respectively. Cash used in investing activities was attributable to purchases of property and equipment.

 

Cash Flows from Financing Activities

 

Cash provided by financing activities for the six months ended June 30, 2018 totaled $5,180,533 which related mostly to cash received from net proceeds from the Company’s initial public offering offset by borrowing and repayments under notes payable. Cash used in financing activities for the six months ended June 30, 2017 was $779,277 which related to the payment of dividends.

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable to smaller reporting companies.

 

ITEM 4.

CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures” as such term is defined in Rule 13a-15(e) under the Exchange Act. In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Based on their evaluation as of the end of the period covered by this report, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective to ensure that the information relating to our company, required to be disclosed in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting 

 

During the three months ended June 30, 2018, there were no changes in our internal control over financial reporting that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II - OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS.

 

We are not currently a party to any material legal proceedings. Although we are not currently a party any material legal proceedings, from time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of these proceedings may result in adverse decisions or settlements, management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows. 

 

ITEM 1A.

RISK FACTORS.

 

Not applicable to smaller reporting companies.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On April 27, 2018, the SEC issued a notice of qualification of our offering statement on Form 1-A (File No. 024-10809), as amended, filed in connection with the IPO. Pursuant to such offering statement, we registered the offering and sale of up to 2,000,000 shares of our common stock by the Company at a price of $5.00 per share. The IPO closed on April 30, 2018.

 

As a result of the IPO, on April 30, 2018, the Company received gross proceeds of $6,562,600 and net proceeds of $5,358,570 after deducting selling agent discounts and commissions of $714,802, and other offering expenses of $1,204,030. See Note 10, Stockholders’ Equity, of the Notes to Condensed Consolidated Financial Statements, in Part I of this Quarterly Report on Form 10-Q for more information. No payments for the foregoing expenses were made by us to any of our officers, directors or persons owning ten percent or more of our Common Stock, or to the associates of any of the foregoing, or to our affiliates.

 

The net proceeds, after paying debt and accrued interest of $700,000, have been invested in cash and cash equivalents. There has been no material change in the expected use of the net proceeds as described in the Company’s offering statement on Form 1-A dated April 25, 2018.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES.

 

None. 

  

ITEM 4.

MINE SAFETY DISCLOSURES.

 

Not applicable. 

 

ITEM 5.

OTHER INFORMATION.

 

Not applicable. 

 

ITEM 6.

EXHIBITS.

 

Exhibit				Incorporated By Reference to						Filed or Furnished
Number		Description		Form		Exhibit		Filing Date		Herewith
2.1		Membership Interest Purchase Agreement by and among Xspand Products Lab, Inc., Edison Nation Holdings, LC and Members of Edison Nation Holdings, LLC, dated June 29, 2018		8-K		10.1		7/6/2018
2.2		Form of LLC Agreement		8-K		10.2		7/6/2018
2.3		Form of Registration Rights Agreement		8-K		10.3		7/6/2018
31.1*		Chief Executive Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002								X
31.2*		Chief Financial Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002								X
32.1+		Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002								X
101.INS*		XBRL Instance Document								X
101.SCH*		XBRL Taxonomy Extension Schema Document								X
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document								X
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document								X
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document								X
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document								X

 

*

Filed herewith.

 

+

This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and it is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: August 14, 2018

	XSPAND PRODUCTS LAB, INC.
	By:	/s/ Christopher B. Ferguson
		Christopher B. Ferguson
		Chairman and Chief Executive Officer
		(Principal Executive Officer)
	By:	/s/ Philip Anderson
		Philip Anderson
		Corporate Secretary and Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)